Control of pathogenic CD8+ T cell migration to the brain by IFN-γ during experimental cerebral malaria

Parasite Immunology

Volumn 30, Issue 10, 2008, Pages 544-553

  Belnoue, E ^b,c   Potter, S M ^b,c   Rosa, D S ^b,c   Mauduit, M ^b,c   Gruner A C ^a,b,c   Kayibanda, M ^b,c   Mitchell, A J ^d   Hunt, N H ^d   Renia L ^a,b,c  

^a Agency for Science   (Singapore)

^b INSTITUT COCHIN   (France)

^c INSERM   (France)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cerebral malaria; Interferon ; Plasmodium berghei ANKA

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MALARIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MIGRATION; CONTROLLED STUDY; LEUKOCYTE MIGRATION; LUNG; LUNG EDEMA; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ANIMALS; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CHEMOKINES; GENE EXPRESSION; INTERFERON TYPE II; LUNG; MALARIA, CEREBRAL; MICE; NEUTROPHILS; PLASMODIUM BERGHEI; RECEPTORS, CHEMOKINE; RECEPTORS, INTERFERON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPLEEN;

MUS; PLASMODIUM BERGHEI;

EID: 51349131945     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2008.01053.x     Document Type: Article

References (35)

1. Miller LH. Baruch DI, Marsh K Doumbo OK. The pathogenic basis of malaria. Nature 2002 415 : 673 679.
2. Coltel N, Combes V, Hunt NH Grau GE. Cerebral malaria - a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res 2004 1 : 91 110.
3. Haldar K, Murphy S, Milner DA Taylor TE. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe diseases. Annu Rev Pathol 2007 2 : 217 252.
4. Taylor T, Fu WJ, Carr RA, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2007 10 : 143 145.
5. Grau GE, Mackenzie CD, Carr RA, et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis 2003 187 : 461 466.
6. Hunt NH Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 2003 24 : 491 499.
7. Engwerda CR, Belnoue E, Gruner AC Renia L. Experimental models of cerebral malaria. Curr Top Microbiol Immunol 2005 297 : 103 143.
8. Renia L, Potter SM, Mauduit M, et al. Pathogenic T cells in cerebral malaria. Int J Parasitol 2006 36 : 547 554.
9. + T cells in experimental cerebral malaria. J Immunol 2002 169 : 6369 6375.
10. Grau GE, Heremans H, Piquet PF, et al. Monoclonal antibody against interferon γ can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci USA 1989 86 : 5572 5574.
11. Amani V, Vigario AM, Belnoue E, et al. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol 2000 30 : 1646 1655.
12. Rudin W, Eugster HP, Bordmann G, et al. Resistance to cerebral malaria in tumor necrosis factor-α/β deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol 1997 150 : 257 266.
13. Engwerda CR, Mynott TL, Sawhney S, et al. Locally up-regulated lymphotoxin α, not systemic tumor necrosis factor α, is the principle mediator of murine cerebral malaria. J Exp Med 2002 195 : 1371 1377.
14. Favre N, Da Laperousaz C, Ryffel B, et al. Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect 1999 1 : 961 968.
15. Huang S, Hendriks W, Althage A, et al. Immune response in mice that lack the interferon-γ receptor. Science 1993 259 : 1742 1745.
16. Hearn J, Rayment N, Landon DN, Katz DR De Souza JB. Immunopathology of cerebral malaria: morphological evidence of parasite sequestration in murine brain microvasculature. Infect Immun 2000 68 : 5364 5376.
17. Irani DN Griffin DE. Isolation of brain parenchymal lymphocytes for flow cytometric analysis. J Immunol Meth 1991 139 : 223 229.
18. Miu J, Mitchell AJ, Muller M, et al. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 Deficiency. J Immunol 2008 180 : 1217 1230.
19. Ebrahimi B, Dutia B, Brownstein DG Nash AA. Murine Gammaherpesvirus-68 infection causes multi-Organ Fibrosis and Alters Leukocyte Trafficking in interferon-γ receptor Knockout Mice. Am J Pathol 2001 158 : 2117 2125.
20. Senaldi G, Vesin C, Chang R, Grau GE Piguet PF. Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun 1994 62 : 1144 1149.
21. Berger O, Gan X, Gujuluva C, et al. CXC and CC chemokine receptors on coronary and brain endothelia. Mol Med 1999 5 : 795 805.
22. Hesselgesser J Horuk R. Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 1999 5 : 13 26.
23. Belnoue E, Kayibanda M, Deschemin JC, et al. CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood 2003 101 : 4253 4259.
24. + T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J Immunol 2007 178 : 5779 5788.
25. Menten P, Wuyts A Van Damme J. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002 13 : 455 481.
26. Yanez DM, Manning DD, Cooley AJ, Weidanz WP van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol 1996 157 : 1620 1624.
27. + T lymphocytes mediate experimental cerebral malaria pathogenesis. J Immunol 2003 170 : 2221 2228.
28. Vigario AM, Belnoue E, Grüner AC, et al. Recombinant human IFN-α inhibits cerebral malaria and reduces parasite burden in mice. J Immunol 2007 178 : 6416 6022.
29. + T-cells prevents Plasmodium berghei induced cerebral malaria in end-stage disease. Parasitology 1997 114 : 7 12.
30. Miu J, Mitchell AJ, Ball HJ Hunt NH (2006) Chemokines and malaria infection. Curr Immunol Rev 2006 2 : 331 344.
31. Belnoue E, Costa FTM, Vigario AM, et al. Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria. Infect Immun 2003 71 : 3648 3651.
32. Campanella GSV, Tager AM, El Khoury JK, et al. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc Natl Acad Sci USA 2008 105 : 4814 4819.
33. Van den Steen PE, Deroost K, Aelst IV, et al. CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN-γ-induced chemokines. Eur J Immunol 2008 38 : 1082 1095.
34. Speyer CL, Gao H, Rancilio NJ, et al. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol 2004 165 : 2187 2196.
35. Koch O, Awomoyi A, Usen S, et al. IFNGR1 gene promoter polymorphisms and susceptibility to cerebral malaria. J Infect Dis 2002 185 : 1684 1687.